204 related articles for article (PubMed ID: 33660317)
1. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis.
Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z
Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317
[TBL] [Abstract][Full Text] [Related]
2. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
3. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.
Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W
Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.
Yan L; Zhang M; Song Q; Xie F; Luo Y
Eur Radiol; 2022 Feb; 32(2):1216-1226. PubMed ID: 34357450
[TBL] [Abstract][Full Text] [Related]
5. The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.
He LY; Chen ML; Wang WW; Balde AI; Li Z; Cai Z; Han S; Lei ST; Zhou MW; Zhang GQ
Int J Clin Exp Pathol; 2017; 10(9):9735-9743. PubMed ID: 31966856
[TBL] [Abstract][Full Text] [Related]
6. Cervical Lymph Node Metastasis Differences in Patients with Unilateral or Bilateral Papillary Thyroid Microcarcinoma: A Multi-Center Analysis.
Yang Z; Heng Y; Qiu W; Tao L; Cai W
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013169
[TBL] [Abstract][Full Text] [Related]
7. Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma.
Zhao H; Cui L
Front Endocrinol (Lausanne); 2021; 12():655608. PubMed ID: 34220708
[TBL] [Abstract][Full Text] [Related]
8. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC).
Kim K; Zheng X; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocrine; 2020 Jul; 69(1):149-156. PubMed ID: 32146654
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
Zhao L; Sun X; Luo Y; Wang F; Lyu Z
Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
[TBL] [Abstract][Full Text] [Related]
10. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
11. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
[TBL] [Abstract][Full Text] [Related]
12. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
[TBL] [Abstract][Full Text] [Related]
13. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
15. Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
Front Endocrinol (Lausanne); 2019; 10():363. PubMed ID: 31275239
[No Abstract] [Full Text] [Related]
16. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
17. BRAF
Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
[TBL] [Abstract][Full Text] [Related]
18. Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC.
Huang H; Xu S; Ni S; Liu W; Liu S
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15525-15533. PubMed ID: 37646829
[TBL] [Abstract][Full Text] [Related]
19. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.
Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L
Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.
Tao Y; Wang C; Li L; Xing H; Bai Y; Han B; Liu Z; Yang X; Zhu S
Mol Clin Oncol; 2017 Jan; 6(1):49-55. PubMed ID: 28123728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
